SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust is experiencing significant momentum, largely fueled by escalating global scarcity concerns and China's impending silver export restrictions, alongside robust industrial demand for critical technologies. Community sentiment is sharply divided between those anticipating a 'generational' price squeeze towards triple digits and warnings of an 'overbought' bubble poised for a sharp correction, reminiscent of past speculative surges in precious metals.

Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Unicycive Therapeutics Inc

Unicycive Therapeutics is trending as the community processes the FDA's Complete Response Letter for OLC, citing manufacturing vendor deficiencies rather than drug efficacy or safety concerns. While this creates immediate investor frustration and questions about potential dilution, the company's plan to resubmit its NDA for a potential approval in 1H 2026 fuels ongoing debate between short-term risks and OLC's perceived best-in-class long-term value.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp (UAMY) is trending amid escalating geopolitical concerns over critical minerals, particularly antimony, with recent reports highlighting China's tightened export controls. The company is actively discussed as the sole domestic supplier of military-grade antimony to the U.S. government, securing substantial defense contracts, yet the community is debating persistent market manipulation and short activity that appears to be suppressing its price. Despite recent volatility, many investors express strong long-term conviction, pointing to its strategic importance and ambitious growth targets into 2026, while anticipating imminent positive news or government support.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is trending due to promising preliminary open-label Phase 3 trial results for its breast cancer immunotherapy, showing an 80% reduction in recurrence rates for a specific patient arm. This positive development, combined with high short interest, a soaring cost-to-borrow, and low share availability, is fueling community speculation about a significant short squeeze and potential buyout offers. Investors are also noting strong insider confidence and the company's strategic financial position, de-risking future prospects.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending following positive news, including significant CEPI funding for its pandemic influenza vaccine candidate and a favorable EMA opinion on its next-generation COVID-19 vaccine. This has ignited bullish community sentiment, with many anticipating a short squeeze and long-term pipeline success despite ongoing skepticism and legal challenges. Investors are debating if the stock, often seen as a biotech sector laggard, is poised for a rebound fueled by institutional interest and its oncology partnership with Merck.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending following the recent FDA approval of YARTEMLEA, the first and only therapy for transplant-associated thrombotic microangiopathy, a significant de-risking event for the company. The community is actively discussing the drug's market monopoly, high revenue potential, and the strengthened balance sheet from a multi-billion dollar partnership. Investors are keenly anticipating further details on pricing and commercialization strategies during an upcoming conference call.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is generating significant discussion driven by its strategic partnership to integrate at-home exam technology and speculation surrounding substantial government initiatives in rural healthcare. While many express acute frustration regarding current leadership and past capital allocation, a strong bullish contingent believes the company is deeply undervalued and poised for a major rebound as a global leader in the rapidly expanding AI healthcare sector.

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire & inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

401JK is trending due to the enthusiastic adoption of its newly launched staking feature, with a significant portion of the token supply quickly locked in by the community. Holders are actively discussing its 'retirement' narrative, viewing it as a robust alternative to traditional financial plans and highlighting the project's strong, diamond-handed community and organic growth on the Solana network. This collective conviction and resilience against market fluctuations contribute to a prevailing bullish sentiment among participants.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is a central topic as investors keenly await the expected delivery of its 100-qubit chip and an upcoming partnership with NVIDIA, both viewed as pivotal catalysts. Bulls foresee a significant rally and short squeeze, while bears highlight past missed deadlines, insider selling, and the company's high valuation. This sharp divergence underscores the speculative, high-risk discussions surrounding the stock within the broader quantum computing sector.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Tempe, AZ.

First Solar Inc

First Solar is a hot topic as it benefits from strategic tailwinds, including Alphabet's acquisition of a major FSLR customer and broad bullish analyst sentiment. Community discussions highlight FSLR's strong position as a domestic manufacturer, crucial for meeting the surging energy demands of AI data centers and capitalizing on favorable U.S. policies. This makes it a standout leader in the evolving solar sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
